Publication | Closed Access

Fumaryl diketopiperazine based effervescent microparticles to escape macrophage phagocytosis for enhanced treatment of pneumonia via pulmonary delivery

Cell-based Drug DeliveryNanomedicinePolymer-drug ConjugateMedicineFumaryl DiketopiperazineImmunologyPulmonary DeliveryDrug Delivery SystemsNano-drug DeliveryMacrophage PhagocytosisDrug Delivery SystemPharmacology